Nucleus Basalis Of Meynert Expanded V2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The nucleus basalis of Meynert (NBM) is the largest cholinergic nucleus in the basal forebrain and serves as the primary source of acetylcholine (ACh) for the entire cortical mantle. Named after Theodor Meynert who first described it in 1872, this structure is critical for cortical activation, attention, learning, and memory consolidation 1. [1]
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:2000056 | Meynert cell |
The NBM is located in the basal forebrain, specifically in the substantia innominata region ventral to the globus pallidus. It consists of clusters of large, cholinergic projection neurons that give rise to widespread cortical afferents. The nucleus is anatomically divided into several subregions: [2]
Each sector maintains topographic organization with corresponding cortical targets 2. [3]
The NBM contains approximately 200,000-500,000 cholinergic neurons in the human brain. These neurons are characterized by: [4]
Beyond acetylcholine, NBM neurons co-release other neurotransmitters and neuromodulators: [5]
The NBM receives inputs from several brain regions: [6]
NBM cholinergic neurons project to virtually all cortical areas: [7]
The cortical projection pattern follows a gradient, with denser innervation of frontal and parietal regions compared to occipital cortex 3.
NBM cholinergic projections are essential for cortical activation and arousal. Acetylcholine release in the cortex:
The NBM-cortical cholinergic system plays a critical role in:
NBM activity modulates sensory cortex responsiveness:
The NBM is severely affected in Alzheimer's disease, with early and prominent degeneration of cholinergic neurons:
The cholinergic hypothesis of AD, proposed in the 1970s, led to the development of acetylcholinesterase inhibitors (donepezil, rivastigmine, galantamine) as symptomatic treatments 4.
NBM integrity can be assessed using:
NBM degeneration predicts:
Neuropsychological testing: Cognitive assessments
Neuroimaging: Structural and functional MRI
Biomarker analysis: CSF and blood markers
Mechanisms/Cholinergic-System-Dysfunction-Pathway
Cell-Types/Basal-Forebrain-Cholinergic-Neurons
Treatments/Acetylcholinesterase-Inhibitors
The study of Nucleus Basalis Of Meynert Expanded V2 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
The NBM shows evolutionary conservation across mammals but with notable species differences:
NBM cholinergic neurons:
The NBM is part of the basal ganglia-cortical loop:
NBM interacts with:
Donepezil (Aricept)
Rivastigmine (Exelon)
Galantamine (Razadyne)
Increas - Enhance cholinergic transmission
Improve cortical activation
Stem cell transplantation
Gene therapy for ChAT expression
NGF delivery
BDNF supplementation
Anti-apo
NBM deep brain stimulation
The nucleus basalis of Meynert is essential for:
Its degeneration in Alzheimer's disease and other neurodegenerative disorders makes it a critical:
Preserving or restoring NBM function remains a key strategy for treating cognitive decline in neurodegenerative diseases.
Ballinger EC, et al. Basal Forebrain Cholinergic Circuits and Signaling in Cognition and Cognitive Decline. 2016. ↩︎
Gielow MR, Zaborszky L. The basal forebrain cholinergic projection system in mice. 2021. ↩︎
Bartus RT, et al. The cholinergic hypothesis of geriatric memory dysfunction. 1982. ↩︎
Kuhn J, et al. Deep brain stimulation of the nucleus basalis of Meynert in Alzheimer's disease. 2019. ↩︎
Schliebs R, Arendt T. The significance of the cholinergic system in the brain during aging and in Alzheimer's disease. 2006. ↩︎
Hampel H, et al. The cholinergic system in the pathophysiology and treatment of Alzheimer's disease. 2019. ↩︎
Craig LA, et al. The专业技术人员 role of basal forebrain cholinergic neurons in cognition. 2011. ↩︎